
Marathon Petroleum, the largest US independent refiner, is exploring the sale of assets of its pipeline subsidiary MPLX LP worth as much as $15 billion, people familiar with the matter said on Wednesday, March 11.
The divestment would give the Findlay, Ohio-based company a cash boost at a time when a looming economic slowdown triggered by the global coronavirus outbreak and lower oil prices are weighing on its prospects. Marathon’s shares have lost half their value in the last three weeks.
Marathon is exploring a sale of MPLX’s gathering and processing (G&P) business, which transports hydrocarbons from drilling sites to major pipelines, the sources said. Intrepid Financial Partners is advising on a sale process for the business, which is at its early stages, the sources added. If there is a deal, it could involve divesting a majority or minority stake in that business, according to the sources.
The sources asked not to be identified because the deliberations are confidential. Marathon, MPLX and Intrepid did not immediately respond to requests for comment.
Marathon had previously said it had formed a special board committee to explore options for its midstream operations, but had not announced a specific course of action.
Featured News
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Rumble Adds David Boies to Legal Team in $2 Billion Antitrust Battle with Google
May 14, 2025 by
CPI
China Summons Delivery Giants Over Unfair Competition Concerns
May 13, 2025 by
CPI
Judge Orders Sanctions Against Missouri for Noncompliance in Price-Fixing Probe
May 13, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas